China Biologic Products Holdings, Inc. announced that its board of directors (the Board) appointed Mr. Joseph Chow as the chief executive officer of the Company, effective August 5, 2019. In early July, the Company received Dr. Huaming He's resignation as Chief Business Officer due to personal reasons.
China Biologic Products Holdings, Inc.
Equities
CBPO
KYG215151047
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+9.58% | 115B | |
+12.41% | 107B | |
-3.49% | 21.6B | |
-12.38% | 22.31B | |
-6.77% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |